Clinical Trials Directory

Trials / Completed

CompletedNCT04639804

Pharmacokinetic Interaction Between Tegoprazan and NSAIDs After Multiple Oral Dosing in Healthy Male Volunteers

An Open-label, Randomized, Crossover Study to Evaluate the Pharmacokinetic Interaction Between Tegoprazan and Non-steroidal Anti-inflammatory Drugs (NSAIDs) After Multiple Oral Dosing in Healthy Male Volunteers

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
60 (actual)
Sponsor
HK inno.N Corporation · Industry
Sex
Male
Age
19 Years – 55 Years
Healthy volunteers
Accepted

Summary

This study aims to evaluate the pharmacokinetic (PK) interaction between tegoprazan and non-steroidal anti-inflammatory drugs (NSAIDs) after given each alone and in their combination in healthy male adults.

Detailed description

A randomized, open-label, multiple-dose, 6-sequence-arm, 3-period cross-over study

Conditions

Interventions

TypeNameDescription
DRUGTegoprazanTegoprazan 50 mg tablet
DRUGNaproxenNaproxen 500 mg tablet
DRUGAceclofenacAceclofenac 100 mg tablet
DRUGCelecoxibCelecoxib 200 mg capsule

Timeline

Start date
2020-06-06
Primary completion
2020-07-26
Completion
2020-07-29
First posted
2020-11-23
Last updated
2020-11-23

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT04639804. Inclusion in this directory is not an endorsement.